Prescription RequiredAbacavir 600 mg + Lamivudine 300 mg (Abamune L) is a combination antiretroviral medicine used to treat HIV-1 infection in adults and children who meet the prescribed weight requirements. It helps reduce the amount of HIV in the body, strengthen the immune system, and lower the risk of HIV-related complications. This medicine is usually taken as part of a combination antiretroviral therapy (ART) regimen and does not cure HIV.
| Generic name | Abacavir/Lamivudine |
| Strength | 600 mg + 300 mg |
| Manufacturer | CIPLA |
| Package size | 1 Bottle of 30 Tablets |
| Used for | HIV-1 Infection |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Abacavir and Lamivudine belong to a class of medicines called nucleoside reverse transcriptase inhibitors (NRTIs). They work by blocking the reverse transcriptase enzyme that HIV needs to multiply. This slows the growth of the virus, lowers the viral load, and helps the immune system function more effectively.
Dr. Dhruv Patel is a qualified medical practitioner with a clinical interest in HIV care and long-term antiretroviral therapy. He helps patients understand how antiretroviral medicines control HIV and why consistent treatment is essential for maintaining viral suppression.
